Chemoinformaics analysis of methyl 2-hydroxybutyrate
| Molecular Weight | 118.132 | nRot | 1 |
| Heavy Atom Molecular Weight | 108.052 | nRig | 1 |
| Exact Molecular Weight | 118.063 | nRing | 0 |
| Solubility: LogS | 0.697 | nHRing | 0 |
| Solubility: LogP | 0.271 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 18 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 8 | No. of Aromatic Carbocycles | 0 |
| nHetero | 3 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 10 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 5 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 3 | No. of Arom Bond | 0 |
| nHA | 3 | APOL | 17.4239 |
| nHD | 1 | BPOL | 12.6361 |
| QED | 0.49 |
| Synth | 2.478 |
| Natural Product Likeliness | 0.812 |
| NR-PPAR-gamma | 0.002 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0 |
| Pgp-sub | 0.002 |
| HIA | 0.012 |
| CACO-2 | -4.581 |
| MDCK | 0.000415676 |
| BBB | 0.991 |
| PPB | 0.1071 |
| VDSS | 0.731 |
| FU | 0.838299 |
| CYP1A2-inh | 0.058 |
| CYP1A2-sub | 0.295 |
| CYP2c19-inh | 0.032 |
| CYP2c19-sub | 0.807 |
| CYP2c9-inh | 0.006 |
| CYP2c9-sub | 0.415 |
| CYP2d6-inh | 0.007 |
| CYP2d6-sub | 0.373 |
| CYP3a4-inh | 0.007 |
| CYP3a4-sub | 0.241 |
| CL | 6.173 |
| T12 | 0.733 |
| hERG | 0.021 |
| Ames | 0.022 |
| ROA | 0.024 |
| SkinSen | 0.126 |
| Carcinogencity | 0.093 |
| EI | 0.955 |
| Respiratory | 0.013 |
| NR-Aromatase | 0.005 |
| Antiviral | No |
| Prediction | 0.965692 |